Show
Sort by
-
Building bridges for innovation in ageing : synergies between action groups of the EIP on AHA
-
Respiratory hypersensitivity reactions to NSAIDs in Europe : the global allergy and asthma network (GA2LEN) survey
-
- Journal Article
- A1
- open access
ARIA 2016 : care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
-
- Journal Article
- A1
- open access
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
-
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation
-
Clinical relevance is associated with allergen-specific wheal size in skin prick testing
-
Integrated care pathways for airway diseases (AIRWAYS-ICPs)
-
Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe
-
Practical guide to skin prick tests in allergy to aeroallergens
-
Severe chronic allergic (and related) diseases : a uniform approach: a MeDALL-GA²LEN-ARIA position paper
-
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs
-
Chronic rhinosinusitis in Europe: an underestimated disease: a GA²LEN study
-
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA2LEN statement
-
GA(2)LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma
-
Development and implementation of guidelines in allergic rhinitis: an ARIA-GA2LEN paper
-
The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper
-
GA2LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe
-
GA2LEN skin test study III: Minimum battery of test inhalent allergens needed in epidemiological studies in patients
-
GA2LEN skin test study I: GA superset of LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe
-
GA(2)LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'